1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA S100B CTRPv2 pan-cancer AAC 0.15 0.0004
mRNA MYLK CTRPv2 pan-cancer AAC -0.14 0.0004
mRNA FERMT2 CTRPv2 pan-cancer AAC -0.14 0.0004
mRNA DVL2 CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA IKBIP CTRPv2 pan-cancer AAC -0.16 0.0004
mRNA SEC22C CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA MPO CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA SERPINB9 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA AC027682.1 CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA TPX2 CTRPv2 pan-cancer AAC -0.12 0.0004
Download CSV